This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom
The drug IDELVION contains one active pharmaceutical ingredient (API):
1
Coagulation factor IX
UNII A57KX1VL5P - ALBUTREPENONACOG ALFA
|
Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B02BD04 | Coagulation factor IX | B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 502619030008507, 502619030008607, 502619030008707, 502619030008807 |
Country: CA | Health Products and Food Branch | Identifier(s): 02451352 |
Country: EE | Ravimiamet | Identifier(s): 1718625, 1718636, 1718647, 1718658, 1826119 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1161095001, 1161095002, 1161095003, 1161095004 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60216127, 63102506, 65247870 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 328156, 328160, 328188, 328194 |
Country: HK | Department of Health Drug Office | Identifier(s): 65142, 65143, 65144, 65145 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8411, 8412, 8413 |
Country: IT | Agenzia del Farmaco | Identifier(s): 044891012, 044891024, 044891036, 044891048, 044891051 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6343448D1020, 6343448D2026, 6343448D3022, 6343448D4029, 6343448D5025 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080374, 1080375, 1080376, 1080377, 1091048 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14281910, 14281929, 14281937 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 132365, 132373, 132403, 132500 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 18603, 18604, 18605, 18606, 22393 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100372514, 100372520, 100372773, 100372796, 100461213 |
Country: SG | Health Sciences Authority | Identifier(s): 15811P, 15812P, 15813P, 15814P |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8681624980330, 8681624980347, 8681624980354, 8681624980361 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.